VWA
GSK icon

Visionary Wealth Advisors’s GSK GSK Stock Holding History

Visionary Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.49M Buy
181,113
+5,524
+3% +$292K 0.37% 77
2026
Q1 		$9.69M Sell
175,589
-33,612
-16% -$1.82M 0.43% 66
2025
Q4 		$10.3M Sell
209,201
-4,040
-2% -$188K 0.46% 57
2025
Q3 		$9.2M Buy
213,241
+241
+0.1% +$9.41K 0.43% 63
2025
Q2 		$8.18M Buy
213,000
+8,218
+4% +$314K 0.42% 66
2025
Q1 		$7.93M Buy
204,782
+11,404
+6% +$417K 0.48% 60
2024
Q4 		$6.54M Buy
193,378
+10,178
+6% +$366K 0.38% 76
2024
Q3 		$7.49M Buy
183,200
+22,930
+14% +$938K 0.46% 68
2024
Q2 		$6.17M Buy
160,270
+70,772
+79% +$2.98M 0.4% 69
2024
Q1 		$3.84M Sell
89,498
-4,136
-4% -$171K 0.26% 104
2023
Q4 		$3.47M Buy
93,634
+131
+0.1% +$4.7K 0.26% 112
2023
Q3 		$3.39M Buy
93,503
+2,798
+3% +$99.3K 0.27% 101
2023
Q2 		$3.23M Buy
90,705
+4,365
+5% +$157K 0.26% 103
2023
Q1 		$3.07M Buy
86,340
+78,514
+1,003% +$2.75M 0.26% 99
2022
Q4 		$275K Buy
+7,826
New +$261K 0.03% 339
2022
Q2 		– Sell
-4,565
Closed -$249K – 452
2022
Q1 		$249K Sell
4,565
-175
-4% -$9.51K 0.02% 367
2021
Q4 		$261K Buy
+4,740
New +$247K 0.02% 320
2020
Q4 		– Sell
-5,662
Closed -$266K – 295
2020
Q3 		$266K Sell
5,662
-2
-0% -$100 0.04% 204
2020
Q2 		$289K Sell
5,664
-357
-6% -$18.3K 0.04% 179
2020
Q1 		$285K Sell
6,021
-15
-0.2% -$800 0.05% 156
2019
Q4 		$354K Buy
+6,036
New +$336K 0.06% 151

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Visionary Wealth Advisors's GSK Position: Q2 2026 in Review

Visionary Wealth Advisors increased its GSK (GSK) stake by 3.1% in Q2 2026, buying an estimated $292K and bringing the position to 181,113 shares worth $9.49M. The position accounts for 0.37% of the portfolio, ranked #77.

Visionary Wealth Advisors first reported a position in GSK in Q4 2019 and has held it in 21 quarters since. The position peaked at $10.3M in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Visionary Wealth Advisors held 181,113 shares of GSK worth $9.49M as of Q2 2026.
  • Visionary Wealth Advisors bought 5,524 GSK shares in Q2 2026, an estimated $292K.
  • GSK made up 0.37% of Visionary Wealth Advisors's portfolio in Q2 2026, its #77 holding.
  • Visionary Wealth Advisors first reported a position in GSK in Q4 2019 and has held it in 21 quarters since.
  • Visionary Wealth Advisors's GSK position peaked at $10.3M in Q4 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Visionary Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.